期刊文献+

灵芝三萜组分增强紫杉醇诱导HER2^+乳腺癌细胞凋亡的研究 被引量:3

Enhancement of Paclitaxel Induced Apoptosis in HER2^+ Breast Cancer Cells by the Triterpene Component of Ganoderma Lucidum
下载PDF
导出
摘要 目的探讨灵芝三萜组分(GLE)增强紫杉醇(PTX)诱导人表皮生长因子受体2阳性(HER2^+)乳腺癌细胞凋亡的作用和机制。方法磺酰罗丹明B(SRB)法和台盼蓝染色计数法检测细胞增殖活性。CompuSyn软件分析药物相互作用。免疫印迹法检测蛋白表达。采用人乳腺癌细胞裸鼠移植瘤模型研究体内抗肿瘤作用。结果体外实验表明,GLE与PTX协同抑制SKBR-3细胞的增殖和诱导细胞凋亡,并协同诱导细胞凋亡相关蛋白的表达和阻断HER2信号通路的传导。体内动物实验表明,GLE增强PTX抗HER2^+乳腺癌的作用。结论GLE与PTX在体内外对HER2^+乳腺癌SKBR-3细胞具有协同抑制作用。 Objective To study the enhancement effect of paclitaxel(PTX)induced apoptosis in HER2+ breast cancer cells by the triterpene component of Ganoderma lucidum(GLE)and its mechanism. Methods Cell proliferation was analyzed by SRB and trypan blue exclusion staining method. The expression of proteins was detected by Western blot. Antitumor activity in vivo was studied in SKBR-3 xenograft model. Results In vitro,GLE and PTX had synergistic effect on the proliferation and induced apoptosis in SKBR-3 cells,and on the upregulation of proteins related to cell apoptosis and blocking transduction of HER2 signaling pathway. In vivo,GLE enhanced antitumor activity of PTX against HER2+ breast cancer. Conclusion GLE and PTX have synergistic antitumor effect against the HER2+ breast cancer cells SKBR-3 both in vitro and in vivo.
出处 《福建医科大学学报》 北大核心 2016年第1期1-5,共5页 Journal of Fujian Medical University
基金 福建省自然科学基金(2015J01678) 福建省自然科学基金青年项目(2010J05068) 福建省高校杰出青年科研人才培育计划(JA13133) 福建省中青年教师教育科研基金资助项目(JA13151) 华南肿瘤学国家重点实验室开放基金(HN2015-05)
关键词 灵芝 三萜类 紫杉酚 乳腺肿瘤 细胞凋亡 协同 Ganoderma lucidum triterpenes paclitaxel breast neoplasms apoptosis coordinative theory
  • 相关文献

参考文献12

  • 1Weaver B A. How taxol/paclitaxel kills cancer cells [J]. Molecular Biology of the Cell, 2014,25 (18) 2677-2681.
  • 2吴秀兰,贾艳,朱波,周杰.天然抗癌药物紫杉醇的研究进展[J].中国野生植物资源,2014,33(5):42-45. 被引量:10
  • 3张龙,王凤玮.紫杉醇用于乳腺癌治疗的应用进展[J].中国医药导报,2014,11(31):167-168. 被引量:6
  • 4黄秀旺,张学鹏,刘锋,李鹏,许建华,李蔓蔓.灵芝三萜组分GLE诱导CNE2细胞凋亡与线粒体途径的关系[J].中国医院药学杂志,2014,34(11):867-869. 被引量:7
  • 5Vichai V, Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening[J]. Nature Protocols, 2006, 1 (3) : 1112-1116.
  • 6Siegel R L, Miller K D,Jemal A. Cancer statistics,2015[J] CA: A Cancer J for Clinicians, 2015,65(1) .-5 29.
  • 7Choi J S,Kim H O,Kim E K,etal. HER2 expression in fine needle aspirates of lymph nodes detected by preoperative axi[ lary ultrasound in breast cancer patients [J]. PLoS One, 2014,9(11) :e113065.
  • 8van Oosterom A T. Docetaxel (Taxotere) : an effective agent in the management of second-line breast cancer[J]. Seminars in Oncology, 1996,22(6 Suppl 13) : 22-28.
  • 9师以康,张胜华,黄云虹,邵荣光,甄永苏.乳腺癌细胞的HER2过表达降低其对紫杉醇的药物敏感性[J].中国药理学通报,2009,25(4):444-448. 被引量:10
  • 10Meearty M F. Targeting multiple signaling pathways as a strategy for managing prostate cancer: multifocal signal modulation therapy[J]. Integrative Cancer Therapies, Z004, 3(4) ..349-380.

二级参考文献72

  • 1王淑月.紫杉醇类似物[J].药学进展,1995,19(3):157-163. 被引量:6
  • 2张晓云,杨春清.灵芝的化学成分和药理作用[J].国外医药(植物药分册),2006,21(4):152-155. 被引量:156
  • 3孔建强,王伟,朱平,程克棣.紫杉醇生物合成的研究进展[J].药学学报,2007,42(4):358-365. 被引量:30
  • 4祝玉祥,范健,周卫,缪玉山.紫杉醇磁性脂质体制备及其性质的研究[J].实用临床医药杂志,2007,11(2):12-15. 被引量:11
  • 5McGrogan B T,Gilmartin B, Carney D N, et al. Taxanes, microtubules and chemoresistant breast cancer[ J]. Biochim Biophys Acta, 2008,85(2) : 96 - 132.
  • 6Pusztai L. Markers predicting clinical benefit in breast cancer from microtubule-targeting agents [ J ]. Ann Oncol, 2007, 18 ( Suppl 12) : xii15 -20.
  • 7Azambuja E, Durbecq V, Rosa D D, et al. HER-2 overexpression/amplification and its interaction with taxane-based therapy in breast cancer[ J]. Ann Orwol,2008,19(2) : 223 -32.
  • 8Jordan M A, Wilson L. Microtubules as a target for anticancer drugs[J]. Nat Rev Cancer, 2004,4(4) : 253 -65.
  • 9Pegram M D, Finn R S, Arzoo K, et al. The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells [ J]. Oncogene, 1997,15 (5) : 537 - 47.
  • 10Yu D, Liu B, Tan M, et al. Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to taxol via mdr-1- independent mechanisms [ J ]. Oncogene, 1996, 13 (6) : 1359 - 65.

共引文献28

同被引文献64

引证文献3

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部